These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10650128)

  • 1. Further evidence for a role of nitric oxide in experimental allergic encephalomyelitis: aminoguanidine treatment modifies its clinical evolution.
    Pozza M; Bettelli C; Aloe L; Giardino L; Calzà L
    Brain Res; 2000 Feb; 855(1):39-46. PubMed ID: 10650128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase.
    Okuda Y; Sakoda S; Fujimura H; Yanagihara T
    J Neuroimmunol; 1998 Jan; 81(1-2):201-10. PubMed ID: 9521623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase.
    Zhao W; Tilton RG; Corbett JA; McDaniel ML; Misko TP; Williamson JR; Cross AH; Hickey WF
    J Neuroimmunol; 1996 Feb; 64(2):123-33. PubMed ID: 8632054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoguanidine-induced amelioration of autoimmune encephalomyelitis is mediated by reduced expression of inducible nitric oxide synthase in the spinal cord.
    Shin T; Kim S; Moon C; Wie M; Kim H
    Immunol Invest; 2000 Aug; 29(3):233-41. PubMed ID: 10933607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of nitric oxide synthase initiates relapsing remitting experimental autoimmune encephalomyelitis in rats, yet nitric oxide appears to be essential for clinical expression of disease.
    O'Brien NC; Charlton B; Cowden WB; Willenborg DO
    J Immunol; 2001 Nov; 167(10):5904-12. PubMed ID: 11698467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.
    Cross AH; Misko TP; Lin RF; Hickey WF; Trotter JL; Tilton RG
    J Clin Invest; 1994 Jun; 93(6):2684-90. PubMed ID: 7515395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis.
    Brenner T; Brocke S; Szafer F; Sobel RA; Parkinson JF; Perez DH; Steinman L
    J Immunol; 1997 Mar; 158(6):2940-6. PubMed ID: 9058833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis.
    Stanislaus R; Singh AK; Singh I
    J Neurosci Res; 2001 Oct; 66(2):155-62. PubMed ID: 11592110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis.
    Okuda Y; Sakoda S; Fujimura H; Yanagihara T
    J Neuroimmunol; 1997 Mar; 73(1-2):107-16. PubMed ID: 9058766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mercaptoethylguanidine scavengers of peroxynitrite on the development of experimental allergic encephalomyelitis in PLSJL mice.
    Scott GS; Kean RB; Southan GJ; Szabó C; Hooper DC
    Neurosci Lett; 2001 Sep; 311(2):125-8. PubMed ID: 11567794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of the cytokine-inducible isoform of nitric oxide synthase induction and nitrosative stress in experimental autoimmune encephalomyelitis of the DA rat.
    Kahl KG; Zielasek J; Uttenthal LO; Rodrigo J; Toyka KV; Schmidt HH
    J Neurosci Res; 2003 Jul; 73(2):198-205. PubMed ID: 12836162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection.
    Rose JW; Hill KE; Wada Y; Kurtz CI; Tsunoda I; Fujinami RS; Cross AH
    J Neuroimmunol; 1998 Jan; 81(1-2):82-9. PubMed ID: 9521609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
    Gold DP; Schroder K; Powell HC; Kelly CJ
    Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin.
    Stanislaus R; Pahan K; Singh AK; Singh I
    Neurosci Lett; 1999 Jul; 269(2):71-4. PubMed ID: 10430507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Hyperosmotic and Immune-Induced Disruption of the Blood-Brain Barrier by the Nitric Oxide System.
    Hasarmeh M; Itzik A; Weidenfeld J; Ovadia H
    Neuroimmunomodulation; 2016; 23(1):1-7. PubMed ID: 26670748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoguanidine reduces apoptosis of circulating V Beta 8.2 T lymphocytes in Lewis rats with actively induced experimental autoimmune encephalomyelitis. Association with persistent inflammation of the central nervous system and lack of recovery.
    Puerta C; Martínez I; Baranda P; Blasco MR; Castejón R; Vargas JA; García-Merino A
    J Neuroimmunol; 2000 Oct; 110(1-2):140-50. PubMed ID: 11024544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis.
    Garcion E; Nataf S; Berod A; Darcy F; Brachet P
    Brain Res Mol Brain Res; 1997 May; 45(2):255-67. PubMed ID: 9149100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type IV phosphodiesterase inhibition in experimental allergic encephalomyelitis of Lewis rats: sequential gene expression analysis of cytokines, adhesion molecules and the inducible nitric oxide synthase.
    Martínez I; Puerta C; Redondo C; García-Merino A
    J Neurol Sci; 1999 Mar; 164(1):13-23. PubMed ID: 10385042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune myocarditis in Lewis rats.
    Shin T; Tanuma N; Kim S; Jin J; Moon C; Kim K; Kohyama K; Matsumoto Y; Hyun B
    J Neuroimmunol; 1998 Dec; 92(1-2):133-8. PubMed ID: 9916888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE.
    Cowden WB; Cullen FA; Staykova MA; Willenborg DO
    J Neuroimmunol; 1998 Aug; 88(1-2):1-8. PubMed ID: 9688317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.